Dental Pain (Following Third Molar Tooth Extraction) Study

Completed · Phase 3

Conditions studied: Dental Pain, Surgery, Dental

In brief

The purpose of this study is to evaluate the effectiveness of GW406381 (a COX-2 inhibitor) in treating the signs and symptoms of dental pain following third molar tooth extraction.

Key facts

Study ID

NCT00114049

Run by

GlaxoSmithKline

People needed

300

Starts

2004-12-01

Expected to finish

2005-04-01

Last updated by the study team

2017-01-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Scheduled for outpatient surgical removal of at least two third molar teeth.

You may not qualify if…

• Subjects who do not achieve moderate to severe pain.
• Subjects who do not use acceptable contraception.
• Additional medical criteria will be assessed by the investigator.

Where it is running

• GSK Investigational Site — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.